Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
1 clinical trials · Condition
◉ Watch Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098 (NCT05473195) | TASK Applied Science | 2022-12-06 |
Track Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) automatically
Every clearance here is in the API, with alerts when new ones post.